Cantor Fitzgerald Initiates Coverage On Annexon with Overweight Rating, Announces Price Target of $40
Cantor Fitzgerald initiates coverage on Annexon (NASDAQ:ANNX) with a Overweight rating and announces Price Target of $40.
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows.
Annexon Q2 EPS $(0.82) Up From $(28.87) YoY
Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.82) per share. This is a 97.16 percent increase over losses of $(28.87) per share from the same period last year.